ロード中...
Lofexidine for acute opioid withdrawal: A clinical case series
INTRODUCTION: Maintaining abstinence through the opioid withdrawal period is a substantial barrier to treatment for patients with opioid use disorder. The alpha-2 agonist lofexidine has demonstrated efficacy and safety in clinical trials, but pragmatic studies describing its use in clinical practice...
保存先:
| 出版年: | Ment Health Clin |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
College of Psychiatric & Neurologic Pharmacists
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534813/ https://ncbi.nlm.nih.gov/pubmed/33062550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2020.09.259 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|